Concepedia

Rupert Sandbrink

RS

Statistics

Publications

67

Citations

13.2K

H-Index

44

Active since

1994

Affiliations

Heinrich Heine University Düsseldorf(Current)

Bayer (Germany)

University Hospital of Basel

University Hospital Bonn

Ottawa Hospital

Rupert Sandbrink is an author at Heinrich Heine University Düsseldorf specializing in multiple sclerosis, neurology, and life sciences.

Publications per year

1994–2018

67

Publications

67

Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration

Jeffrey S. Heier, David M. Brown, Victor Chong et al. · Ophthalmology · 2012 · 2.5K citations

, , +16

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Alasdair Coles, Cary Twyman, Douglas L. Arnold et al. · The Lancet · 2012 · 1.2K citations · Full text

, , +11

Intravitreal Aflibercept Injection for Neovascular Age-related Macular Degeneration

Ursula Schmidt‐Erfurth, Peter K. Kaiser, Jean‐François Korobelnik et al. · Ophthalmology · 2013 · 811 citations

, , +14

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Ludwig Kappos, C. H. Polman, Mark S. Freedman et al. · Neurology · 2006 · 677 citations

, , +12

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes

Ludwig Kappos, Chris H. Polman, Mark S. Freedman et al. · American Journal of Ophthalmology · 2006 · 551 citations

, , +12

1–5 of 67